Drug Approval | July 31, 2023
Dr. Mandaviya urged the stakeholders to capitalize on the current opportunities
Pheezee is designed to assess musculoskeletal and neuromuscular health.
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
Bayer reported the highest market capitalization growth of 23.1% during Q1 2023
The Theme of the event was 'Building One Health Together – Improving Health Equity'
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
MoES have identified a potent Anti-cancer molecule named GS/IICT5/6
The Applied Biosystems TaqPath PCR kits have been analytically- and clinically-validated for use in patient care
Qure.ai is scaling-up the integration of its AI-powered chest x-ray interpretation tool that can benefit early and easy detection of lung diseases including lung cancer.
Subscribe To Our Newsletter & Stay Updated
